These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1680345)

  • 21. Circadian variation of ischaemic events in patients with chronic stable angina: pathophysiological and therapeutical considerations.
    Chierchia SL
    Arch Mal Coeur Vaiss; 1993 Jun; 86 Spec No 3():11-4. PubMed ID: 7904444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian variation of the total ischemic burden and influence by beta-blocking agents.
    Fox KM; Mulcahy DA
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S100-4. PubMed ID: 11527111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Consequences of circadian variability for the treatment of ischemic heart disease].
    Herren T; Urban P; Rutishauser W
    Schweiz Rundsch Med Prax; 1992 Feb; 81(7):176-82. PubMed ID: 1535952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group.
    Willich SN; Linderer T; Wegscheider K; Leizorovicz A; Alamercery I; Schröder R
    Circulation; 1989 Oct; 80(4):853-8. PubMed ID: 2571430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition and management of myocardial ischemia.
    Prida X; Pepine CJ
    Compr Ther; 1987 Apr; 13(4):6-11. PubMed ID: 2882886
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pathophysiologic mechanisms of myocardial ischemia and an approach to drug therapy in patients].
    Pavlović M; Hadzi-Pesić Lj
    Srp Arh Celok Lek; 1987 Jul; 115(7):789-93. PubMed ID: 2908374
    [No Abstract]   [Full Text] [Related]  

  • 27. Beta-adrenergic blockers in silent myocardial ischemia.
    Pepine CJ; Hill JA; Imperi GA; Norvell N
    Am J Cardiol; 1988 Jan; 61(3):18B-21B. PubMed ID: 2893528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circadian variations in cardiac disease: clinical implications. Current strategies for preventing MI, dysrhythmias, sudden death.
    Lundberg GP; Liebson PR; Calvin JE
    J Crit Illn; 1995 Oct; 10(10):693-6, 699-700, 705-7. PubMed ID: 10155744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circadian patterns of myocardial ischemia: pathophysiologic and therapeutic considerations.
    Gottlieb SO
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S18-21. PubMed ID: 2467121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myocardial infarction--coronary thrombosis and salvage of the ischemic myocardium.
    Maroko PR; Ribeiro LG; Goldberg S
    Cardiovasc Clin; 1983; 14(1):191-201. PubMed ID: 6137280
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
    Raos V; Bergovec M
    Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circadian variation and triggers of onset of acute cardiovascular disease.
    Muller JE; Tofler GH; Stone PH
    Circulation; 1989 Apr; 79(4):733-43. PubMed ID: 2647318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Theoretical considerations in the use of calcium entry blockers in silent myocardial ischemia.
    Crawford MH
    Circulation; 1989 Dec; 80(6 Suppl):IV74-7. PubMed ID: 2574641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic rationale for the management of silent ischemia.
    Fox KM; Mulcahy DA
    Circulation; 1990 Sep; 82(3 Suppl):II155-60. PubMed ID: 2203562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angina: current approaches to diagnosis, drug therapy, and surgical referral.
    Renlund DG; Gerstenblith G
    Geriatrics; 1986 Jan; 41(1):35-9, 42, 44 passim. PubMed ID: 2867006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current concepts of silent myocardial ischemia.
    Bleske BE; Shea MJ
    Clin Pharm; 1990 May; 9(5):339-57. PubMed ID: 1972045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Asymptomatic myocardial ischemia in the dynamics of anaprilin and korinfar treatment].
    Volkov VI; Ermakovich II; Strona VI
    Lik Sprava; 1997; (5):114-7. PubMed ID: 9491715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of beta-adrenergic blocking agents on the circadian occurrence of ischemic cardiovascular events.
    Goldstein S
    Am J Cardiol; 1990 Nov; 66(16):63G-65G. PubMed ID: 1978547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of silent myocardial ischemia with transdermal nitroglycerin added to beta-blockers and alprazolam.
    Shell WE; Swan HJ
    Cardiol Clin; 1986 Nov; 4(4):697-704. PubMed ID: 2877735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.